Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting. [electronic resource]
Producer: 20031125Description: 2560-7 p. digitalISSN:- 1524-4628
- Abciximab
- Aged
- Angioplasty -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Anticoagulants -- adverse effects
- Blood Vessel Prosthesis Implantation -- adverse effects
- Brain Ischemia -- etiology
- Carotid Stenosis -- drug therapy
- Cell Aggregation -- drug effects
- Chemotherapy, Adjuvant
- Cohort Studies
- Female
- Fibrinolytic Agents -- adverse effects
- Filtration
- Hemorrhage -- chemically induced
- Humans
- Immunoglobulin Fab Fragments -- adverse effects
- Ischemic Attack, Transient -- drug therapy
- Male
- Monocytes -- drug effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Stents -- adverse effects
- Thromboplastin -- metabolism
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.